Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
Emmanuel Mignot(Stanford University), Thomas Roth(INTEGRIS Baptist Medical Center), Damien Léger(Université Paris Cité), David Mayleben(Clinical Trial and Consulting), Ingo Fietze(Humboldt-Universität zu Berlin), Gary Zammit(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dalma Seboek Kinter(Idorsia (Switzerland)), Claudio L. Bassetti(Swisscom (Switzerland)), Scott Pain(Idorsia (Switzerland))
Cited by 240
Related Papers
European guideline for the diagnosis and treatment of insomnia
|Journal of Sleep Research|2017|2k
Short Sleep Duration as a Risk Factor for Hypertension
|Hypertension|2006|1.2k
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Narcolepsy with cataplexy
|The Lancet|2007|716
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
|Journal of Sleep Research|2023|703